Filings activity in SLXN during Q1 2026, grouped by how each filer changed its position.
No institutions fully exited this quarter.
SLXN Institutional Ownership by Quarter
7 quarters of 13F filings · Δ columns show change vs prior quarter
Quarter
Inst. Holders
Δ Holders
Ownership %
Δ Ownership
Total 13F Value
Δ Value
Q1 2026
7
+17%
0.53%
+0.26 pp
$0M
+33%
Q4 2025
6
+50%
0.27%
+0.20 pp
$0M
+103%
Q3 2025
4
50%
0.07%
0.21 pp
$0M
92%
Q2 2025
8
+33%
0.28%
0.12 pp
$0M
12%
Q1 2025
6
+50%
0.40%
+0.24 pp
$0M
+0.7%
Q4 2024
4
33%
SLXN — Frequently Asked Questions
Quick answers to the most common questions about buying SLXN stock.
What percentage of SLXN is owned by institutions?
Based on Q1 2026 13F filings, institutional ownership of Silexion Therapeutics Ltd. stands at 0.5%, held across 7 reporting institutions.
Who is the largest institutional holder of SLXN?
CITADEL ADVISORS LLC is the largest reported institutional holder of SLXN, with approximately 20,926 shares worth $0.00B as of Q1 2026.
Is SLXN a hedge fund favorite?
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of SLXN, including CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC.
What is SLXN's Smart Money Score?
Our composite Smart Money Score for SLXN is 76 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in SLXN — a direct measure of their conviction.
0.16%
0.05 pp
$0M
53%
Q3 2024
6
—
0.21%
—
$1M
—
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
1 institutions opened new positions in SLXN during Q1 2026, while 0 fully exited. 1 added to existing positions and 5 trimmed.
How is institutional ownership of SLXN changing?
SLXN institutional ownership rose by 0.26 percentage points quarter-over-quarter, with a net change of +1 holders.
How concentrated is SLXN ownership among the top holders?
The top 10 institutions account for 100.0% of all reported 13F value in SLXN, and the top 25 account for 100.0%.
Where does this SLXN institutional ownership data come from?
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Silexion Therapeutics Ltd. (SLXN) Institutional Ownership